Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of V117957 in Subjects With an Alcohol Use Disorder Who Are Experiencing Insomnia Associated With Alcohol Cessation
Conditions
Interventions
V117957 tablets
Placebo
Locations
17
United States
California Clinical Trials Medical Group
Glendale, California, United States
Artemis Institute for Clinical Research
Riverside, California, United States
Artemis Institute for Clinical Research
San Diego, California, United States
CITrials
Santa Ana, California, United States
SDS Clinical Trials, Inc.
Santa Ana, California, United States
St. Francis Medical Institute
Clearwater, Florida, United States
Start Date
September 23, 2019
Primary Completion Date
November 6, 2020
Completion Date
November 6, 2020
Last Updated
September 18, 2023
NCT06032377
NCT06181643
NCT06807086
NCT07429578
NCT05780814
NCT06348082
Lead Sponsor
Imbrium Therapeutics
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions